Financial Statements — KAPA
Balance Sheet
(in millions USD)| Metric | Q2
2026 | Q1
2026 | Q3
2025 | Q2
2025 | Q1
2025 | Q3
2024 |
|---|
| Cash & Equivalents | 2.63 | 3.68 | 5.58 | 3.03 | 3.62 | 3.22 |
| Total Current Assets | 3.17 | 4.44 | 6.66 | 4.84 | 6.05 | 4.74 |
| Intangible Assets | 0.19 | 0.19 | 0.10 | 0.14 | 0.18 | 0.26 |
| Total Non-current Assets | 1.28 | 1.30 | 1.41 | 1.83 | 1.89 | 0.26 |
| Total Assets | 4.46 | 5.74 | 8.07 | 6.67 | 7.94 | 5.00 |
| Accounts Payable | 0.27 | 0.43 | 0.40 | 0.68 | 0.81 | 1.53 |
| Total Current Liabilities | 0.27 | 0.43 | 0.40 | 0.68 | 0.81 | 1.67 |
| Total Non-current Liabilities* | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Total Liabilities* | 0.27 | 0.43 | 0.40 | 0.68 | 0.81 | 1.67 |
| Retained Earnings | (17.30) | (15.92) | (12.90) | (11.50) | (10.08) | (7.83) |
| Total Stockholder Equity | 4.19 | 5.31 | 7.66 | 6.00 | 7.13 | 3.33 |
* Derived from reported values
Income Statement
(in millions USD) (except per-share rows)| Metric | Q2
2026 | Q1
2026 | Q4
2025 | Q3
2025 | Q2
2025 | Q1
2025 | Q4
2024 | Q3
2024 |
|---|
| Research & Development | 0.62 | 0.68 | 0.54 | 0.61 | 0.50 | 0.49 | 0.17 | 0.01 |
| Selling, General & Admin | 0.80 | 1.01 | 0.88 | 0.83 | 0.96 | 0.77 | 1.27 | 0.37 |
| Total Operating Expenses | 1.42 | 1.69 | 1.42 | 1.44 | 1.46 | 1.27 | 1.45 | 0.38 |
| Operating Income | (1.42) | (1.69) | (1.41) | (1.43) | (1.46) | (1.27) | (1.45) | (0.38) |
| Net Income | (1.39) | (1.65) | (1.36) | (1.40) | (1.42) | (1.26) | (0.98) | (1.05) |
| Basic EPS | (0.06) | (0.08) | (0.49) | (0.07) | (0.08) | (0.08) | (0.56) | (0.10) |
| Diluted EPS | (0.06) | (0.08) | (0.49) | (0.07) | (0.08) | (0.08) | (0.56) | (0.10) |
Cash Flow Statement
(in millions USD)| Metric | Q2
2026 | Q1
2026 | Q4
2025 | Q3
2025 | Q2
2025 | Q1
2025 | Q4
2024 | Q3
2024 |
|---|
| Operating Cash Flow | (1.01) | (1.04) | (1.08) | (0.84) | (0.80) | (0.71) | (1.80) | (2.15) |
| Financing Cash Flow | (0.04) | 0.22 | 0.00 | 3.38 | 0.22 | 3.06 | (0.14) | 5.28 |
